InfuSystem Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2023

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Years Ended December 31,
	2023				2022				2021
	Total Net Revenues		% of Total Net Revenues		Total Net Revenues		% of Total Net Revenues		Total Net Revenues		% of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	2,294	1.8	%	$	2,236	2.0	%	$	2,480	2.4	%
Third-Party Payer products	13,821		11.0	%	12,573		11.4	%	12,112		11.8	%
Patient Services revenue recognized over time:
Direct rental services	7,388		5.9	%	7,246		6.6	%	7,333		7.2	%
Third-Party Payer rental services	44,475		35.4	%	40,948		37.3	%	38,765		37.9	%
Total Patient Services accounted for under ASC 606	67,978		54.1	%	63,003		57.3	%	60,690		59.3	%
Device Solutions revenue recognized at a point in time:
Products	14,877		11.8	%	15,359		14.0	%	15,296		14.9	%
Services	9,844		7.8	%	6,434		5.9	%	4,718		4.6	%
Device Solutions revenue recognized over time:
Services	6,038		4.8	%	633		0.6	%	—		—	%
Total Device Solutions accounted for under ASC 606	30,759		24.4	%	22,426		20.5	%	20,014		19.5	%
Total Revenue Accounted for under ASC 606	98,737		78.5	%	85,429		77.8	%	80,704		78.8	%
Patient Services Lease Revenue	8,563		6.8	%	5,878		5.3	%	4,908		4.8	%
Device Solutions Lease Revenue	18,485		14.7	%	18,607		16.9	%	16,770		16.4	%
Total Revenue accounted for under ASC 842, Leases	27,048		21.5	%	24,485		22.2	%	21,678		21.2	%
Total Net Revenue	$	125,785	100.0	%	$	109,914	100.0	%	$	102,382	100.0	%